BIO-key International (NASDAQ:BKYI) Shares Pass Below 50 Day Moving Average – Here’s Why

BIO-key International Inc. (NASDAQ:BKYI) shares crossed below its 50 day moving average during trading on Tuesday . The stock has a 50 day moving average of $5.47 and traded as low as $4.25. BIO-key International shares last traded at $4.40, with a volume of 5,038 shares.

Wall Street Analysts Forecast Growth

Separately, Weiss Ratings reiterated a “sell (e+)” rating on shares of BIO-key International in a report on Monday, April 20th. One investment analyst has rated the stock with a Sell rating, Based on data from MarketBeat, the stock presently has an average rating of “Sell”.

BIO-key International Stock Performance

The firm has a market capitalization of $4.77 million, a P/E ratio of -0.63 and a beta of 0.45. The stock has a fifty day simple moving average of $5.47 and a two-hundred day simple moving average of $6.33. The company has a debt-to-equity ratio of 0.17, a current ratio of 1.26 and a quick ratio of 1.13.

BIO-key International (NASDAQ:BKYI) last issued its earnings results on Tuesday, March 31st. The technology company reported ($0.19) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.70) by $0.51. The business had revenue of $1.24 million during the quarter, compared to the consensus estimate of $2.20 million. BIO-key International had a negative return on equity of 67.43% and a negative net margin of 75.32%.

Institutional Investors Weigh In On BIO-key International

A hedge fund recently raised its stake in BIO-key International stock. Geode Capital Management LLC boosted its holdings in BIO-key International Inc. (NASDAQ:BKYI) by 49.9% in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 48,892 shares of the technology company’s stock after purchasing an additional 16,271 shares during the quarter. Geode Capital Management LLC owned about 0.45% of BIO-key International worth $26,000 at the end of the most recent quarter. 26.51% of the stock is owned by institutional investors and hedge funds.

About BIO-key International

BIO-key International, Inc is a developer and provider of fingerprint biometric identity and access management solutions, serving enterprise and government customers. The company’s core offerings include a range of fingerprint readers and authentication software designed to verify user identity across physical and digital environments. By leveraging proprietary template-on-card and template-on-device technologies, BIO-key seeks to enhance security and streamline user access without reliance on traditional passwords.

In addition to hardware sensors, BIO-key delivers software platforms that integrate with existing IT infrastructures such as Microsoft Active Directory and major workforce management systems.